STRATA CRITICAL MEDICAL, INC.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | $41.3M | $-27.3M | $-56.1M | $-27.3M | $-40.1M | $-20.5M | $2.3M |
| Depreciation & Amortization | $8.2M | $6.0M | $7.1M | $5.7M | $596.0K | $526.0K | $472.0K |
| Depreciation | $4.3M | $2.0M | $1.1M | $830.0K | $830.0K | $336.0K | $289.0K |
| Amortization | $2.6M | $1.3M | $6.0M | $4.9M | $243.0K | $190.0K | $183.0K |
| Stock-Based Compensation | $17.8M | $19.9M | $12.5M | $8.3M | $9.6M | $490.0K | $317.0K |
| Net Cash from Operating Activities | $-48.9M | $-2.5M | $-32.3M | $-37.1M | $-15.6M | $-794.5K | $-10.3M |
| Investing Activities | |||||||
| Capital Expenditures | $9.6M | $30.9M | $2.1M | $730.0K | $297.0K | $377.0K | $604.0K |
| Business Acquisitions | $66.5M | $2.2M | $0 | $48.1M | $23.1M | $0 | $0 |
| Net Cash from Investing Activities | $69.8M | $-1.0M | $17.1M | $79.3M | $-321.3M | $334.9K | $-1.1M |
| Financing Activities | |||||||
| Dividends Paid | — | — | — | — | — | — | — |
| Stock Repurchases | $0 | $244.0K | $0 | — | — | — | — |
| Net Cash from Financing Activities | $-8.9M | $-5.8M | $-76.0K | $-1.1M | $332.3M | $1.2M | $116.0K |
| Net Change in Cash | $11.6M | $-9.4M | $-15.4M | $41.2M | $-4.7M | $-459.5K | $-11.2M |
| Free Cash Flow | $-58.5M | $-33.4M | $-34.5M | $-37.9M | $-15.9M | $-1.2M | $-10.9M |